The Role of Clinical Data, Content, and Workflow in Selecting Study Sites

The Role of Clinical Data, Content, and Workflow in Selecting Study Sites

Press Release ( - Toronto, Canada - Jan 16, 2018 - On Wednesday, January 24, 2018 at 1 p.m. EST Xtalks will host a complimentary webinar with Veeva Systems and Paragon Solutions. Topics will include how to use content, data, and workflow together to significantly optimize the site selection and activation processes. In providing shared visibility to key stakeholders, objectively selecting the right site for the right study is clearer and site performance and scoring is also improved.

Speakers Ashley Davidson, director of Vault Study Startup at Veeva Systems, and Chris McSpirit, clinical practice lead at Paragon Solutions, will discuss how improving collaboration between sponsors, site partners, and CROs during site selection can help avoid clinical trial delays.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit


Nima Rajan
​Tel: +1 (416) 977-6555 ext 352

Source : Xtalks
Business Info :


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.